45 employees
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.
2019
$91M
from 3 investors over 3 rounds
Treadwell Therapeutics, Inc. raised $91M on November 18, 2021
Investors: Prosperous Alliance, Sino Biopharmaceutical Limited and TIO Bioventures